Dealmed

Dealmed is a prominent player in medical and pharmaceutical supply distribution, offering over 25,000 products with a niche-focused approach and a commitment to swift delivery. The company differentiates itself by leading a tech-driven revolution in medical supply distribution, notably through advanced inventory monitoring and predictive replenishment. This emphasis on innovation extends to reducing costs, understanding product suitability for various procedures, and standardizing practices across different settings and locations. Dealmed boasts an emphasis on domestically sourced products and advanced technology that integrates with clients’ PO systems. It also provides end-to-end solutions for warehousing, inventory, and distribution, making its third-party logistics program as seamless as any first-party operation. The company offers exclusive access to leading brands, originals, and alternatives, along with rapid access to exclusive contracts, GPOs, and tiered pricing. Additionally, Dealmed provides priority access to manufacturers’ backorders and hard-to-get products. Dealmed serves a diverse range of customers, including hospitals, healthcare systems, physician offices, ambulatory surgery centers, urgent and community healthcare centers, dialysis centers, EMS and first responders, government agencies, and consumer and specialty markets. The company's services encompass medical supply distribution, medical equipment, pharmaceuticals and vaccines, surgical supplies and equipment, specialty market distribution, and 3PL services. Established in 2006, Dealmed has a strong footing in the healthcare and medical devices industries. As a potential investment opportunity, Dealmed's emphasis on technology, innovative supply chain solutions, and diverse customer base presents an attractive proposition for venture capitalists seeking exposure to the healthcare sector.